Advances in Pediatric Drug Formulations
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 February 2025 | Viewed by 1322
Special Issue Editors
Interests: orodispersible dosage forms; pediatric dosage forms; freeze-drying; quality by design drug development; product/process optimization; design of experiments; texture analysis in pharmaceutical product characterization
Special Issues, Collections and Topics in MDPI journals
Interests: innovative dosage forms; drug delivery systems; quality by design (QbD); process analytical technology (PAT); multivariate data analysis (MVDA); 3D printing in pharmaceutics; novel methods of drugs manufacturing; pharmaceutical process optimization
Special Issues, Collections and Topics in MDPI journals
Interests: development and characterization of solid and semisolid dosage forms; texture analysis; development and optimization of cosmetic products based on nanocarriers or herbal extracts
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The low availability of appropriate pediatric medications remains a focal point for researchers and pharmaceutical manufacturing companies. Although efforts have been made to stimulate the authorization of pediatric medications, the needs of patients are still far away from being fulfilled. Lately, new solid dosage forms, such as orodispersibles, minitablets, thin films, and 3D-printed dosage forms, have been proposed as alternatives to liquids for different age groups, along with novel devices that ease pediatric drug administration. However, this field requires further research and innovation in terms of the appropriate excipients, product and process development, taste masking, and quality assessment methods. Also, understanding end-user perception and acceptability is needed to guide product formulation and grant treatment adherence. While pediatric drug availability, as well as details on preparation, manipulation, administration practices, and preferences, have long been documented in developed countries, data coming from developing regions are scarce.
We extend an invitation to all stakeholders, including academia, pharmaceutical companies, hospital/community pharmacies, patient associations, and regulatory authorities, to share their results in the aforementioned matters and bridge the knowledge gaps that currently limit the development of pediatric drugs.
Dr. Sonia M. Iurian
Prof. Dr. Ioan Tomuță
Dr. Catalina Bogdan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric dosage forms
- child-friendly dosage forms
- age-appropriate dosage forms
- acceptability
- administration devices
- taste-masking
- compounded pediatric formulations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
